氨苄西林-舒巴坦和头孢哌酮-舒巴坦对苯唑西林敏感和耐药葡萄球菌的体外活性
In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.
作者信息
Barry A L, Jones R N
机构信息
Clinical Microbiology Institute, Tualatin, Oregon 97062.
出版信息
Antimicrob Agents Chemother. 1990 Sep;34(9):1830-2. doi: 10.1128/AAC.34.9.1830.
Abstract
Ampicillin-sulbactam and cefoperazone-sulbactam were tested against staphylococci that were collected from 40 different medical centers throughout the United States. Oxacillin-resistant strains were resistant to both drug combinations, but oxacillin-susceptible strains were uniformly susceptible. The latter included strains with borderline susceptibility to oxacillin and methicillin.
摘要
氨苄西林-舒巴坦和头孢哌酮-舒巴坦针对从美国40个不同医疗中心收集的葡萄球菌进行了测试。耐苯唑西林菌株对这两种药物组合均耐药，但苯唑西林敏感菌株均敏感。后者包括对苯唑西林和甲氧西林敏感性处于临界值的菌株。
相似文献
1
In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.氨苄西林-舒巴坦和头孢哌酮-舒巴坦对苯唑西林敏感和耐药葡萄球菌的体外活性
Antimicrob Agents Chemother. 1990 Sep;34(9):1830-2. doi: 10.1128/AAC.34.9.1830.
2
3
Comparison of ampicillin/sulbactam and amoxicillin/clavulanic acid for detection of borderline oxacillin-resistant Staphylococcus aureus.
Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):47-51. doi: 10.1007/BF01971271.
4
5
Survey of clinical isolates of Staphylococcus aureus for borderline susceptibility to antistaphylococcal penicillins.金黄色葡萄球菌临床分离株对苯唑西林类抗生素临界敏感性的调查。
Eur J Clin Microbiol Infect Dis. 1993 Sep;12(9):677-82. doi: 10.1007/BF02009379.
6
In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis.β-内酰胺类药物及舒巴坦对沙眼衣原体的体外活性
Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):371-3. doi: 10.1016/0732-8893(92)90027-q.
7
In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.舒巴坦/氨苄西林对意大利医院分离出的耐氨苄西林产β-内酰胺酶细菌的体外活性。
Chemotherapy. 1990;36(2):141-6. doi: 10.1159/000238760.
8
In-vitro antimicrobial studies with the combination of cefoperazone and sulbactam.头孢哌酮与舒巴坦联合的体外抗菌研究。
J Antimicrob Chemother. 1993 Dec;32(6):912-3. doi: 10.1093/jac/32.6.912.
9
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.将他唑巴坦-哌拉西林与舒巴坦-氨苄西林、克拉维酸-替卡西林、舒巴坦-头孢哌酮及哌拉西林进行比较，观察其对从复杂性尿路感染患者中分离出的产β-内酰胺酶细菌的抗菌活性。
J Chemother. 1997 Apr;9(2):89-94. doi: 10.1179/joc.1997.9.2.89.
10
Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.氨苄西林-舒巴坦和苯唑西林在由高产β-内酰胺酶的金黄色葡萄球菌引起的实验性心内膜炎中的活性。
Antimicrob Agents Chemother. 1993 Mar;37(3):507-11. doi: 10.1128/AAC.37.3.507.
引用本文的文献
1
Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam.使用预测性检测板评估氨苄西林-舒巴坦的药敏试验方法。
Antimicrob Agents Chemother. 1993 Feb;37(2):251-9. doi: 10.1128/AAC.37.2.251.
2
Use of a predictor panel to evaluate susceptibility test methods proposed for piperacillin-tazobactam.使用预测指标组评估针对哌拉西林-他唑巴坦提出的药敏试验方法。
Antimicrob Agents Chemother. 1993 Dec;37(12):2578-83. doi: 10.1128/AAC.37.12.2578.
3
Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.使用预测性检测板开发用于头孢哌酮-舒巴坦扩散试验的新型试纸条。
Antimicrob Agents Chemother. 1992 Feb;36(2):394-400. doi: 10.1128/AAC.36.2.394.
本文引用的文献
1
Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.肉汤微量稀释法在耐甲氧西林（异质性耐药）葡萄球菌药敏试验中的成功应用。
J Clin Microbiol. 1983 Nov;18(5):1084-91. doi: 10.1128/jcm.18.5.1084-1091.1983.
2
Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus.与金黄色葡萄球菌β-内酰胺耐药性相关的低亲和力青霉素结合蛋白。
J Bacteriol. 1984 May;158(2):513-6. doi: 10.1128/jb.158.2.513-516.1984.
3
Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.氨苄西林加β-内酰胺酶抑制剂（CP-45,899）治疗金黄色葡萄球菌所致实验性心内膜炎的疗效
J Infect Dis. 1981 Sep;144(3):237-43. doi: 10.1093/infdis/144.3.237.
4
Penicillin-binding proteins and the intrinsic resistance to beta-lactams in gram-positive cocci.青霉素结合蛋白与革兰氏阳性球菌对β-内酰胺类抗生素的固有耐药性
J Antimicrob Chemother. 1985 Oct;16(4):412-6. doi: 10.1093/jac/16.4.412.
5
Regulation of penicillin-binding protein activity: description of a methicillin-inducible penicillin-binding protein in Staphylococcus aureus.青霉素结合蛋白活性的调节：金黄色葡萄球菌中一种甲氧西林诱导型青霉素结合蛋白的描述。
Antimicrob Agents Chemother. 1985 May;27(5):828-31. doi: 10.1128/AAC.27.5.828.
6
In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.头孢哌酮-舒巴坦组合的体外抗菌谱、协同作用的发生情况以及稀释药敏试验浓度的建议。
J Clin Microbiol. 1987 Sep;25(9):1725-9. doi: 10.1128/jcm.25.9.1725-1729.1987.
7
Role of beta-lactamase and different testing conditions in oxacillin-borderline-susceptible staphylococci.β-内酰胺酶及不同检测条件在苯唑西林临界敏感葡萄球菌中的作用
Antimicrob Agents Chemother. 1988 Dec;32(12):1754-7. doi: 10.1128/AAC.32.12.1754.
8
Proposed changes in interpretive criteria and potency of ampicillin and ampicillin-sulbactam disks for susceptibility tests.关于氨苄西林及氨苄西林-舒巴坦药敏试验纸片的解释标准和效力的拟议变更。
J Clin Microbiol. 1988 Apr;26(4):750-4. doi: 10.1128/jcm.26.4.750-754.1988.
9
Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination.氨苄西林-舒巴坦组合的最佳稀释药敏试验条件、MIC解释建议及质量控制指南。
J Clin Microbiol. 1987 Oct;25(10):1920-5. doi: 10.1128/jcm.25.10.1920-1925.1987.
10
Methicillin-resistant staphylococci.耐甲氧西林葡萄球菌
Clin Microbiol Rev. 1988 Apr;1(2):173-86. doi: 10.1128/CMR.1.2.173.
Zotero 插件